Critically, we have demonstrated that [177Lu]Lu-DUNP19 therapy can be effective despite heterogenous LRRC15 expression within tumor tissue, and in contexts where the tumor cells themselves do not express the target. The gene discussed is LRRC15; the disease is neoplasm.